Professor Chris Packard reviews the latest evidence showing that triglyceride-rich lipoproteins and their remnants can initiate and progress atherogenesis, and discusses the potential of novel and existing agents in regulating remnant lipoproteins.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
